Clinical benefits of novel non ‐nucleoside reverse transcriptase inhibitors: A prospective cohort study

ConclusionsBoth regimens showed good virological effectiveness; however, compared with ANV+3TC+TDF, the EFV+3TC+TDF regimen reduced the prevalence of HIV-related symptoms.

Source: Immunity, Inflammation and Disease - April 5, 2024 Category: Allergy & Immunology Authors: Shujing Ma, Xiaoxin Xie, Yanhua Fu, Lin Gan, Xiaoyan Yang, Linghong Kong, Jun Li, Hai Long Tags: ORIGINAL ARTICLE Source Type: research